Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
Clinical trial NCT02461589 · COMPLETED
Trial details
- NCT number
- NCT02461589
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-21
- Primary completion
- 2016-10-13
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.